BRAF mutation and tumor immune microenvironment in new era.
Activation of the BRAF kinase is implicated in the oncogenesis of multiple human tumors, particularly thyroid cancer, colorectal cancer and melanoma.
APA
Zhou J, Li C, et al. (2026). BRAF mutation and tumor immune microenvironment in new era.. American journal of cancer research, 16(2), 371-387. https://doi.org/10.62347/IRQS3605
MLA
Zhou J, et al.. "BRAF mutation and tumor immune microenvironment in new era.." American journal of cancer research, vol. 16, no. 2, 2026, pp. 371-387.
PMID
41868670
Abstract
Activation of the BRAF kinase is implicated in the oncogenesis of multiple human tumors, particularly thyroid cancer, colorectal cancer and melanoma. BRAF mutations serve as pivotal modulators of the immunomodulatory landscape within tumors, critically shaping host immune responses and modulating efficacy to cancer immunotherapy. Here, we reviewed the impact of BRAF mutations on the composition and function of tumor immune microenvironment and summarized current therapeutic strategies targeting BRAF. Overall, BRAF mutations significantly modulates cancer treatment outcomes through its effects on immune regulation. Targeting BRAF mutations at different stages of tumor initiation and progression may provide valuable insights for the development of innovative clinical interventions.
같은 제1저자의 인용 많은 논문 (5)
- Prognostic comparison of transoral laser microsurgery for early glottic cancer with or without anterior commissure involvement: A meta-analysis.
- Oriental nose elongation using an L-shaped polyethylene sheet implant for combined septal spreading and extension.
- Impact of visceral obesity on postoperative complications and oncological outcomes in elderly patients with colorectal cancer.
- Replication stress-inducing ELF3 upregulation promotes BRCA1-deficient breast tumorigenesis in luminal progenitors.
- Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis.